CT导向下经皮射频消融术治疗肾上腺恶性肿瘤  

CT-guided percutaneous radiofrequency ablation in the treatment of malignant adrenal neoplasms

作　　者：张亮[1] 吴沛宏[1] 范卫君[1] 张福君[1] 黄金华[1] 李传行[1] 赵明[1] 顾仰葵[1] 肖鹏[1] 

机构地区：[1]华南肿瘤学国家重点试验室 中山大学附属肿瘤医院影像介入中心,广州510060

出　　处：《中华放射学杂志》2006年第9期962-965,共4页Chinese Journal of Radiology

摘　　要：目的对29例肾上腺肿瘤患者行射频消融(RFA)治疗,研究其近期局部治疗效果、不良反应和副作用。方法肾上腺肿瘤患者共29例,病灶总数31个,其中直径≤2.0 cm 的病灶共5个,2.1～4.0 cm 者18个,4.1～6.0 cm 者5个,≥6.1 cm 者3个,经 RFA 治疗1个月后行螺旋 CT双期增强扫描评价肿瘤治疗效果。结果上述病灶经消融治疗后达到完全坏死者分别为5个、18个、3个、2个。患者无严重并发症出现。结论 RFA 治疗安全可靠,副作用小,是治疗肾上腺恶性肿瘤的有效方法之一。Objective To analyze the local therapeutic efficacy, side effect, and complications of malignant adrenal neoplasms by CT-guided percutaneous radiofrequency ablation （RFA）. Methods RFA was performed on 31 malignant adrenal tumors in 29 patients under the guidance of CT scanning, The diameter size of the tumors was as follows： ≤2.0 cm in 5 tumors, 2.1-4.0 cm in 18, 4.1-6.0 cm in 5, and ≥ 6.1 cm in 3. The results were evaluated by the double-phase CT scanning one month after the therapy, Results The complete coagulative necrosis rate was 23/23 in tumors with diameter of less than 4. 0 cm. In tumors with diameter larger than 4, 1 cm, the complete coagulative necrosis rate was 5/8, Conclusion RFA was safe, effective and reliable in the treatment of malignant adrenal neoplasms.

关 键 词：导管消融术 肾上腺肿瘤 评价研究 

分 类 号：R736.6[医药卫生—肿瘤]